NEW YORK (GenomeWeb) – Pacific Biosciences on Thursday filed a shelf registration to offer up to $150 million of its securities.
According to a document filed with the US Securities and Exchange Commission, the company may offer and sell from time to time shares of its common stock, preferred stock, depositary shares, warrants, debt securities, or units comprising its securities.
PacBio previously filed a $150 million shelf registration in April 2012.
The company had $99.3 million in cash and cash equivalents as of Sept. 30. In the third quarter, PacBio's revenues climbed 178 percent year over year to $20.6 million.